Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07389694
Eligibility Criteria:
Inclusion Criteria:
* Age from 18 to 65 years
* Self-identifies as a person who currently stutters
* Right-handed or left-handed
* Normal hearing and (corrected) vision
* Able to understand and give informed consent
* Monolingual English speaker
Exclusion Criteria:
* Cardiac pacemaker or pacemaker wires; neurostimulators; implanted pumps
* Metal in the body (rods, plates, screws, shrapnel, dentures, IUD) or metallic particles in the eye
* Facial tattoos
* Not having medical insurance
* Surgical clips in the head or previous neurosurgery
* Any magnetic particles in the body
* Cochlear implants
* Prosthetic heart valves
* Epilepsy or any other type of seizure history
* History of significant head trauma (i.e., extended loss of consciousness, neurological sequelae)
* Known structural brain lesions
* Pre-existing speech, language, or neurological disorder (except for stuttering)
* Significant other disease (heart disease, malignant tumors, mental disorders)
* Significant claustrophobia; Ménière's disease
* Women who are trying to get pregnant and sexually active women (of reproductive age) not on a reliable contraceptive
* Pregnancy, breastfeeding
* Medications increasing the risk for seizures
* Non-prescribed drug use
* Use of recreational drugs such as medical marijuana
* Failure to perform the behavioral tasks or neuropsychological evaluation tests
* Prisoners
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT07389694
Study Brief:
Protocol Section:
NCT07389694